These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A license to print money? Nat Biotechnol; 2006 Jun; 24(6):593. PubMed ID: 16763570 [No Abstract] [Full Text] [Related]
25. Patent watch: Progress in three key patent disputes in 2009. Nat Rev Drug Discov; 2010 Jan; 9(1):12-3. PubMed ID: 20050395 [No Abstract] [Full Text] [Related]
26. Patent infringement. Generic HIV drugmaker's patent claim is time-barred. AIDS Policy Law; 2003 Aug; 18(16):6. PubMed ID: 14626916 [No Abstract] [Full Text] [Related]
27. A precarious balancing act--the role of the FDA as protector of public health and industry wealth. McCabe AR Suffolk Univ Law Rev; 2003; 36(3):787-819. PubMed ID: 16493844 [No Abstract] [Full Text] [Related]
28. Innovators working hard to avoid patent exclusions in the US. Tombling A Drug Discov Today; 2013 Dec; 18(23-24):1131-2. PubMed ID: 24120891 [No Abstract] [Full Text] [Related]
30. Preliminary injunctions in generic and branded patent litigation. Cohen S; England P Expert Opin Ther Pat; 2013 Sep; 23(9):1083-6. PubMed ID: 23855903 [No Abstract] [Full Text] [Related]
31. Proposed changes to patent code loom over biotech industry. Coombs A Nat Biotechnol; 2007 Dec; 25(12):1333-4. PubMed ID: 18066010 [No Abstract] [Full Text] [Related]
32. [Novartis should discontinue its patent case in India!]. PehrOlov P Lakartidningen; 2007 Feb 14-20; 104(7):524. PubMed ID: 17375688 [No Abstract] [Full Text] [Related]
33. Patent battle lines drawn as sofosbuvir gains approval. Harrison C Nat Rev Drug Discov; 2014 Jan; 13(1):12. PubMed ID: 24378791 [No Abstract] [Full Text] [Related]
34. Pharmaceutical patent settlements: the antitrust risks. Balto DA Food Drug Law J; 2000; 55(3):321-41. PubMed ID: 11824464 [No Abstract] [Full Text] [Related]
35. How would patent reform legislation in the United States impact the pharmaceutical industry? Williams AW Expert Opin Ther Pat; 2015 Feb; 25(2):131-3. PubMed ID: 25387953 [TBL] [Abstract][Full Text] [Related]
36. India remains on US trade "priority watch list" for failing to uphold international drug company patents. Arie S BMJ; 2013 May; 346():f2949. PubMed ID: 23657189 [No Abstract] [Full Text] [Related]
37. Biotech patents-business as usual? Lawrence S Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861 [No Abstract] [Full Text] [Related]
38. Patents: the public interest versus the private privilege. Parsi KP; Egan EA Am J Bioeth; 2002; 2(3):45-6. PubMed ID: 12230857 [No Abstract] [Full Text] [Related]
39. Pfizer receives US$2.15 billion in patent damages. Sklan A Pharm Pat Anal; 2013 Sep; 2(5):583. PubMed ID: 24386655 [No Abstract] [Full Text] [Related]
40. US policy may encourage counterfeit drugs. Bouchie A Nat Biotechnol; 2003 Feb; 21(2):121. PubMed ID: 12560826 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]